🔗 Share this article

An underground market for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.

Investigational Treatment Acquiring Traction Online

Retatrutide, which remains in research studies, is being advertised by social media influencers for its supposed weight-reducing effects. Followers are encouraged to message these accounts directly for source information, while also receiving discount codes.

Active Commerce on Social Networks

Additionally, a robust trade exists on messaging services, where groups with numerous of members share comparison photos, administration instructions and claims of next-day British shipping. Vendors market the substance there before redirecting customers to other platforms for purchases.

Understanding The Experimental Drug

This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help patients reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Medical Professionals Express Worries

Nevertheless, doctors and pharmacists have cautions that the distribution of what remains an unapproved medication in the UK is a cause for concern and could result in users injecting products of uncertain source.

Several professionals stated the demand for the experimental drug could be connected to the rising cost of licensed slimming treatments such as Mounjaro.

Regulatory Position and Implementation

Selling the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unlicensed medication that cannot be marketed or supplied for human use under the British medical regulations.

Some influencers try to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still breach medicines, marketing, and consumer regulations, potentially leading to penalties, prosecution or imprisonment.

Platform Reaction and Content Removal

Based on TikTok, the service has removed violative material and prohibited associated keywords and search suggestions. The company said it was committed to keeping the platform secure and allocating resources in strengthening enforcement strategies.

Digital Trading Activities

Investigations also discovered communities with up to 9,000 participants selling retatrutide using Telegram's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” immediately brings up groups with numerous of users, populated with images of slimming results, positive reviews and step-by-step guides for mixing or administering at home.

Within minutes of joining one community, a vendor shared contact information, where most transactions occur. The seller provided an guidebook and guaranteed shipping within 48 hours. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None asked about body mass, medical conditions or previous experience.

Product Information and Pricing

Inside these communities, messages display black plastic packages with Royal Mail stickers, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with sterile water, or ready-to-use pens usually sold at 160 pounds for 20mg. When asked how much time a pen should be used, vendors give contradictory answers ranging from a several days to “depends on your body”.

Service Moderation and Safety Measures

A representative for Telegram stated it actively monitored harmful material on its service including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are administering materials they can’t verify. Even if the research behind retatrutide is sound, these online versions may not include what they claim,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor connected the increase in interest to current cost increases for approved weight-loss drugs such as Mounjaro. “With costs rising, patients are turning to online platforms. But fake injections are extremely dangerous. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she explained.

Her team has previously encountered patients injured by personal administration from unverified sources. “We understand the frustration, but purchasing from messaging apps or communication platforms is taking chances with your health,” stated Wyllie. “These substances could be contaminated or improperly measured.”

Producer Position

A representative from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for human use,” they explained, noting that any item “falsely representing itself as a Lilly experimental product not yet approved … may subject users to possibly significant medical dangers”.